Abstract

Alpha-synucleinopathies are featured by fibrillar inclusions in brain cells. Although α-synuclein fibrils display structural diversity, the origin of this diversity is not fully understood. We used molecular dynamics simulations to design synthetic peptides, based on the NAC 71-82 amino acid fragment of α-synuclein, that govern protofilament contacts and generation of twisted fibrillar polymorphs. Four peptides with structures based on either single or double fragments and capped or non-capped ends were selected for further analysis. We determined the fibrillar yield and the structures from these peptides found in the solution after fibrillisation using protein concentration determination assay and circular dichroism spectroscopy. In addition, we characterised secondary structures formed by individual fibrillar complexes using laser-tweezers Raman spectroscopy. Results suggest less mature fibrils, based on the lower relative β-sheet content for double- than single-fragment peptide fibrils. We confirmed this structural difference by TEM analysis which revealed, in addition to short protofibrils, more elongated, twisted and rod-like fibril structures in non-capped and capped double-fragment peptide systems, respectively. Finally, time-correlated single-photon counting demonstrated a difference in the Thioflavin T fluorescence lifetime profiles upon fibril binding. It could be proposed that this difference originated from morphological differences in the fibril samples. Altogether, these results highlight the potential of using peptide models for the generation of fibrils that share morphological features relevant for disease, e.g., twisted and rod-like polymorphs.

Highlights

  • Patients suffering from the neurodegenerative diseases Parkinson’s disease (PD), Lewy body dementia (LBD) and multiple system atrophy (MSA) display fibrillar inclusions of α-synuclein in neuronal and glial cells [1,2,3]

  • We designed a series of synthetic peptides based on the non-amyloid-β component (NAC) 71-82 amino acid fragment of α-synuclein to yield a variety of fibril structures

  • We characterised the fibrillisation process (CD spectroscopic and Bicinchoninic acid (BCA) analyses) and found, using laser-tweezers Raman spectroscopy (LTRS), that the β-sheet content in endpoint fibrils was lower in double-fragment compared to singlefragment peptide fibrils

Read more

Summary

Introduction

Patients suffering from the neurodegenerative diseases Parkinson’s disease (PD), Lewy body dementia (LBD) and multiple system atrophy (MSA) display fibrillar inclusions of α-synuclein in neuronal and glial cells [1,2,3]. It is believed that the cell toxicity and associated pathology of a fibril are correlated to its structure, the whole picture is not fully understood—the role of different polymorphs and toxicity is still under debate. This knowledge gap has in turn limited the development of diagnostic methods that could be used to propose more efficient drug therapies for fibril-induced neurodegenerative diseases. Αsynuclein in solution has been characterised as an intrinsically disordered protein, contact with surfaces and other macromolecules can induce it into folded conformations. Lowering the polarity of the solution by the presence of aliphatic alcohols can, in turn, induce β-sheet folds [8]

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call